Uma "pequena" janela para os "dramas" da indústria:
AstraZeneca's Lynparza fails in gastric cancer combination test | Daily Mail Online
Citando:
"AstraZeneca's recently approved ovarian cancer drug Lynparza failed to increase overall survival significantly when given with chemotherapy to patients with gastric cancer in a late-stage trial, the drugmaker said on Wednesday.
The news is a setback for the British drugmaker, which reported positive results with an experimental acute asthma drug on Tuesday, although the result may have limited read-across for Lynparza in other cancer settings."
